Skip to content
10-Q

Quarterly Report

ESCALON MEDICAL CORP ESMC

0000862668-24-000030

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Nov 13, 2024 7.42M sh
Current Liabilities Q1 2025 · Sep 30, 2024 $2.68M
Current Liabilities Q1 2025 · Jun 30, 2024 $2.67M
Total Liabilities Q1 2025 · Sep 30, 2024 $2.94M
Total Liabilities Q1 2025 · Jun 30, 2024 $2.95M
Current Assets Q1 2025 · Sep 30, 2024 $4.45M
Current Assets Q1 2025 · Jun 30, 2024 $4.4M
Total Assets Q1 2025 · Sep 30, 2024 $4.72M
Total Assets Q1 2025 · Jun 30, 2024 $4.76M
Shares Diluted Q1 2025 · Sep 30, 2023 7.42M sh
Capex Q1 2025 · Sep 30, 2023 $18.33K
Operating Cash Flow Q1 2025 · Sep 30, 2023 −$115.96K
Stockholders Equity Q1 2025 · Sep 30, 2023 $1.91M
Stockholders Equity Q1 2025 · Jun 30, 2023 $1.93M
Eps Diluted Q1 2025 · Sep 30, 2023 $0.00
Eps Basic Q1 2025 · Sep 30, 2023 $0.00
Sga Expense Q1 2025 · Sep 30, 2023 $1.1M
Rd Expense Q1 2025 · Sep 30, 2023 $211.65K
Net Income Q1 2025 · Sep 30, 2023 −$21.2K
Operating Income Q1 2025 · Sep 30, 2023 −$15.65K
Cost Of Revenue Q1 2025 · Sep 30, 2023 $1.65M